The contractor shall test interventional agents in atory and specialized assays in standard format (i.e., cell culture plates with 96 or fewer wells) with the objective of identifying and…
Ended Awarded Last action
- Contract number
- 75N93020F00001
- Awardee
-
Southern Research Institute UEI CDZJAJJHJMH5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $146,812
Award facts
- Contract value 100% obligated
- $146,812.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Birmingham, AL 35205, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$7,495 | |
| Original award | $154,307 |
About this award
This is a cost-plus-fixed-fee Delivery Order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Southern Research Institute, a non-profit research organization, with a potential value of $146,812.16. The contract is for the contractor to test interventional agents in laboratory and specialized assays with the objective of identifying and characterizing at least one agent with activity. This work supports the "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" major program. Southern Research Institute has previously provided a range of research and development services to federal agencies including NIH, the Centers for Disease Control and Prevention (CDC), the Department of Energy, and the Department of Defense.
Description
The contractor shall test interventional agents in atory and specialized assays in standard format (i.e., cell culture plates with 96 or fewer wells) with the objective of identifying and characterizing at least one (1) agent with activity to
Quick answers
Who was awarded contract 75N93020F00001?
75N93020F00001 was awarded to Southern Research Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 1, 2020.
How much is contract 75N93020F00001 worth?
The government has obligated $146,812 on 75N93020F00001.
Is contract 75N93020F00001 an order under another contract?
Yes. 75N93020F00001 is a delivery order under HHSN272201400010I, an indefinite delivery contract.
Was contract 75N93020F00001 competed?
The extent of competition for 75N93020F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award